摘要
我国2009版基本药物目录与世界卫生组织(WHO)和及相关国家的基本药物目录(EML)的比较分析,并以我国疾病负担为依据,对我国基本药物目录的合理性加以探析,提出相应的政策建议。
By comparing the National Essential Medicines List （ Edition 2009 ） of China with those of WHO and some countries, and considering Chinese burden of diseases, the rationality of Chinese National Essential Medicines List was analyzed. Based on which, some policy suggestions were put forward.
出处
《中国卫生事业管理》
北大核心
2011年第1期38-39,共2页
Chinese Health Service Management
关键词
基本药物
国家基本药物目录
数量
essential medicine
National Essential Medicines List
quantity.
